1,960 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 885 increasing their positions, 763 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9891,960 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 286234 (-52)

Holders
1,960
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$351M
2 +$340M
3 +$281M
4
Renaissance Technologies
Renaissance Technologies
New York
+$240M
5
JP Morgan Chase
JP Morgan Chase
New York
+$183M
Name Holding Trade Value Shares
Change
Change in
Stake
1476
$803K
1477
$798K
1478
$796K
1479
$794K
1480
$792K
1481
$792K
1482
$789K
1483
$785K
1484
$783K
1485
$780K
1486
$779K
1487
$777K
1488
$774K
1489
$773K
1490
$770K
1491
$768K
1492
$767K
1493
$759K
1494
$757K
1495
$755K
1496
$753K
1497
$748K
1498
$747K
1499
$747K
1500
$745K